Bausch Health News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

03.08.21	Bausch Health To Reduce Debt By $350 Million (PR Newswire)
03.08.21	Bausch Health To Reduce Debt By $350 Million (PR Newswire)
02.08.21	Bausch Health Completes Sale Of Amoun Pharmaceutical To ADQ (PR Newswire)
02.08.21	Bausch Health Completes Sale Of Amoun Pharmaceutical To ADQ (PR Newswire)
29.07.21	Ortho Dermatologics Announces 2021 Aspire Higher Scholarship Recipients (PR Newswire)
29.07.21	Ortho Dermatologics Announces 2021 Aspire Higher Scholarship Recipients (PR Newswire)
22.07.21	Salix Announces 2021 Gastrointestinal Health Scholars Program Winners (PR Newswire)
22.07.21	Salix Announces 2021 Gastrointestinal Health Scholars Program Winners (PR Newswire)
19.07.21	Bausch + Lomb Will Present 14 Scientific Posters Featuring New Analyses Involving Its Surgical Technologies At The 2021 Annual Meeting Of The American Society Of Cataract And Refractive Surgery (PR Newswire)
19.07.21	Bausch + Lomb Will Present 14 Scientific Posters Featuring New Analyses Involving Its Surgical Technologies At The 2021 Annual Meeting Of The American Society Of Cataract And Refractive Surgery (PR Newswire)
12.07.21	Bausch + Lomb Launches Biotrue® Hydration Boost Lubricant Eye Drops and Biotrue® Micellar Eyelid Cleansing Wipes (PR Newswire)
12.07.21	Bausch + Lomb Launches Biotrue® Hydration Boost Lubricant Eye Drops and Biotrue® Micellar Eyelid Cleansing Wipes (PR Newswire)
07.07.21	Bausch + Lomb Completes Enrollment Of Second Phase 3 Study For NOV03 (perfluorohexyloctane) (PR Newswire)
07.07.21	Bausch + Lomb Completes Enrollment Of Second Phase 3 Study For NOV03 (perfluorohexyloctane) (PR Newswire)
06.07.21	Bausch Health Companies Inc. Will Release Second-Quarter 2021 Financial Results On August 3 (PR Newswire)
06.07.21	Bausch Health Companies Inc. Will Release Second-Quarter 2021 Financial Results On August 3 (PR Newswire)
01.07.21	Bausch Health To Reduce Debt By $150 Million Using Cash Generated From Operations (PR Newswire)
01.07.21	Bausch Health To Reduce Debt By $150 Million Using Cash Generated From Operations (PR Newswire)
23.06.21	Bausch + Lomb Expands Parameters for Bausch + Lomb ULTRA® Multifocal for Astigmatism Contact Lenses (PR Newswire)
23.06.21	Bausch + Lomb Expands Parameters for Bausch + Lomb ULTRA® Multifocal for Astigmatism Contact Lenses (PR Newswire)
22.06.21	Bausch Health Announces Extension Of Its Tender Offer For Cash Tender Offer For Senior Secured Notes By One Business Day To Reflect The Federal Holiday On June 18, 2021 (PR Newswire)
22.06.21	Bausch Health Announces Extension Of Its Tender Offer For Cash Tender Offer For Senior Secured Notes By One Business Day To Reflect The Federal Holiday On June 18, 2021 (PR Newswire)
21.06.21	Bausch Health Announces D. Robert Hale Has Resigned From Its Board Of Directors (PR Newswire)
21.06.21	Bausch Health Announces D. Robert Hale Has Resigned From Its Board Of Directors (PR Newswire)
08.06.21	Bausch + Lomb and Lochan Enter Into Agreement to Develop the Next-Generation of eyeTELLIGENCE™ Clinical Decision Support Software (PR Newswire)
08.06.21	Bausch + Lomb and Lochan Enter Into Agreement to Develop the Next-Generation of eyeTELLIGENCE™ Clinical Decision Support Software (PR Newswire)
16.04.21	Bausch Announces Approval Of VYZULTA In Brazil - Quick Facts (RTTNews)
13.04.21	Bausch + Lomb : First Phase 3 Trial Of NOV03 On Dry Eye Disease Meets Primary And Secondary Goals (RTTNews)
31.03.21	Bausch Health Enters Deal To Sell Equity Interests In Amoun - Quick Facts (RTTNews)
11.03.21	Bausch Health Promotes Sam Eldessouky To Succeed Paul Herendeen As CFO - Quick Facts (RTTNews)
24.02.21	Bausch Health Q4 Loss Narrows; To Add Two Designees To Board From Carl Icahn (RTTNews)
30.12.20	Bausch Health's Dexaven Gets New Indication In Poland To Treat Patients With COVID-19 (RTTNews)
29.12.20	Bausch Health To Pay Down Additional $275 Mln Of Debt - Quick Facts (RTTNews)
12.10.20	Bausch Health Acquires License For Investigational Atropine Ophthalmic Solution (RTTNews)
21.09.20	Bausch Health To Acquire Ophthalmology Assets Of Allegro - Quick Facts (RTTNews)
13.09.20	Week Ahead In Pharma: FDA Decisions, Data Readouts, ESMO Presentations (RTTNews)
27.08.20	Biotech Stocks Facing FDA Decision In September (RTTNews)
13.08.20	VIE Joins COVID-19 Fight, CBMG To Be Taken Private, FDA Postpones Decision On EM-100, ONTX On Watch (RTTNews)
06.08.20	Bausch Health Plans To Spin Off Eye Health Business (RTTNews)
27.07.20	Biotech Stocks Facing FDA Decision In August 2020 (RTTNews)
29.04.20	BPMC's VOYAGER Fails, CLSD's NDA Resubmission Faces Delay, SNDX Hits New High (RTTNews)
05.12.19	Bausch Health (BHC) Hits A New High, What Next? (RTTNews)
02.12.19	Biotech Stocks Facing FDA Decision In December 2019 (RTTNews)
15.11.19	Healthcare Stocks That Hit New Highs (CBPO, CNMD, BHC...) (RTTNews)
27.02.19	Synergy Stock Plunges As Bausch Health Confirmed As Successful Bidder For Assets (RTTNews)
24.02.19	ACHV Soared As Much As 145%. What Awaits SRPT, HTBX, KPTI This Week? (RTTNews)
20.02.19	FDA Nod For NVO's Hemophilia A Drug, ICPT's NASH Trial Hits Goal, NVTA Abuzz (RTTNews)
13.02.19	What Awaits Bausch Health This Month? (RTTNews)
30.01.19	Biotech Stocks Facing FDA Decision In February (RTTNews)
04.01.19	Nicox Says Its Partner Receives Approval In Canada Of VYZULTA (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Bausch Health

Aktien Top/Flop

Meistgelesene Nachrichten